Not yet recruiting
Lung carcinoma cell type unspecified recurrent
Not yet recruitingStudy of Durvalumab with Thoracic Radiotherapy and Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer After Initial Treatment
Registered drugNo placebo
Study of Durvalumab with Thoracic Radiotherapy and Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer After Initial Treatment
Registered drugNo placebo
- Disease:Lung carcinoma cell type unspecified recurrent
- Substances:Durvalumab
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Durvalumab
- Sponsor:Azienda Ospedaliero Universitaria Di Modena